Patent · US Active

Manufacture, compositions and uses of coagulation factor VIIa modulator

US8552046B2 · kind B2 · utility

2Cited by
2References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 16, 2008
Grant dateOct 8, 2013
Priority date—
Expiry dateFeb 17, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D235/18
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Treatment of cancer and thromboembolic disorders using inhibitors of Factor VIIa are disclosed herein using a compound of Formula I.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.